Trials / Completed
CompletedNCT03800563
Laser Assisted Liposuction and Facial Autologous Fat Grafting With the LipoLife System
The Safety and Efficacy of Laser Assisted Liposuction and Facial Autologous Fat Grafting With the LipoLife System
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Alma Lasers · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Multi-center, prospective, open-label, single arm study. The study aims to evaluate the safety and efficacy of Laser Assisted Liposuction procedure performed with the LipoLife system. The study will include twenty (20) eligible subjects, that are willing to undergo abdominal or outer thighs laser-assisted liposuction. Five to twenty (5-20) subjects out of this study group should also be eligible for facial fat grafting. Follow up visits to evaluate study endpoints will take place at 1, 3 and 6 months after the surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | LipoLife system | Abdominal/ Outer thighs Laser Assisted Liposuction. Five to twenty subjects out of the study group will also undergo facial fat grafting. |
Timeline
- Start date
- 2018-11-06
- Primary completion
- 2019-09-10
- Completion
- 2020-05-20
- First posted
- 2019-01-11
- Last updated
- 2022-10-25
- Results posted
- 2022-10-25
Locations
2 sites across 2 countries: United States, Israel
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03800563. Inclusion in this directory is not an endorsement.